- Aviva’s Solvency II in the first quarter (1Q) matches estimates at 206% (year-on-year up from 196%).
- The company remains confident in meeting the Group targets which include £2 billion of operational profit by 2026.
- Furthermore, Aviva plans to generate £1.8 billion Solvency II own funds by 2026.
- The business also projects more than £5.8 billion cash remittances cumulative from 2024 to 2026.
- Numbers for 1Q are promising, with General Insurance premiums showing a 16% increase up to £2.7 billion.
- Wealth net flows have also increased by 15%, matching the General Insurance premiums at £2.7 billion.
- Analysts’ ratings on Aviva are favorable: there are 12 buys, 5 holds, and 2 sells.
A look at Aviva Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Aviva PLC, an international insurance company offering a wide range of general and life assurance services, has been assigned a set of Smart Scores indicating its overall outlook. With strong ratings in Dividend, Growth, Resilience, and Momentum, Aviva is positioned well for long-term success. The company excels in providing consistent dividends to its shareholders and shows promising growth potential, supported by its resilient business model and positive momentum in the market.
Overall, Aviva’s solid performance across key factors like Dividend, Growth, Resilience, and Momentum underscores its strength and stability in the insurance industry. Investors looking for a reliable and growing company may find Aviva an attractive long-term investment option based on the Smartkarma Smart Scores assessment.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
